Pharmacologic and Medical Advances in Obesity Management

Obesity is a chronic, progressive, relapsing, multifactorial disease resulting in metabolic and biomechanical morbidities and premature mortality, and its prevalence has risen to unacceptable levels in the United States and worldwide. Healthy diet, exercise, and behavioral interventions are crucial components of management but are largely unsuccessful in achieving and maintaining weight reduction sufficient to reduce morbidities and prevent premature mortality because the chronic neuroendocrine disease of obesity remains unaddressed. Despite recognition that long-term antiobesity medications and potentially bariatric procedures are required to mitigate the effects of obesity, knowledge gaps, misperceptions, and bias are highly prevalent. Recently approved and emerging antiobesity medications are revolutionizing obesity treatment by achieving long-term weight loss previously unattainable without surgical intervention. Reversing the low utilization of medication and surgical treatment begins with ending the stigmatization of patients with obesity.

The purpose of this course is to ensure that providers have current and accurate knowledge regarding the available pharmacologic and surgical options to improve outcomes among their patients, with the ultimate goal of improving patient care and outcomes.


Learning Objectives

  1. Define obesity and related conditions.
  2. Outline approaches to the clinical assessment of patients who are overweight or obese.
  3. Review the epidemiology of obesity, including the evolving obesity epidemic.
  4. Compare and contrast available energy expenditure research.
  5. Describe the role of diet, physical activity, and body mass index (BMI) on the etiology of obesity.
  6. Identify other etiologic factors contributing to the obesity epidemic.
  7. Evaluate current knowledge of energy balance and defense of body weight in the regulation of body weight.
  8. Define the four pillars of obesity management.
  9. Analyze pharmacotherapeutic options for monogenic obesity syndromes.
  10. Compare available pharmacotherapy for short- and long-term management of obesity.
  11. Identify investigational antiobesity medications in development.
  12. Review prescribing tips to improve the clinical use of antiobesity medications.
  13. Outline available metabolic and bariatric surgical interventions, including indications, contraindi­cations, and efficacy.
  14. Discuss the role of endoscopic bariatric therapies in the management of obesity.
  15. Describe the physiology and pathophysiology underlying obesity and driving advances in the management of obesity.

Additional Information

Course summary
Available credit: 
  • 15.00 AMA PRA Category 1 Credit
  • 15.00 ANCC
Course opens: 
Course expires: 

Available Credit

  • 15.00 AMA PRA Category 1 Credit
  • 15.00 ANCC


Please login or register to take this course.

NetCE Course Number: #94280

This course is offered through NetCE.

To take this course you will be redirected to NetCE website. You must login or create an account with NetCE in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch